SUBSCRIBE
SUBSCRIBE
News   Business

Dr. Reddy’s Laboratories, Inc. in Supply Deal with SYGNIS Pharma AG, Germany

November 26, 2007 | 
1 min read

Dr Reddy’s Laboratories has signed an exclusive 10 year agreement with Germany-based Sygnis Pharma AG for the supply of an ingredient used in the treatment of stroke and other neurodegenrative disorders.

Alliances Asia Europe
MORE ON THIS TOPIC
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period
December 19, 2024
 · 
3 min read
 · 
Tristan Manalac
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
December 19, 2024
 · 
1 min read
 · 
Annalee Armstrong
Business
Analysis vs Beliefs, CEO Challenges, GLP-1 Investments
December 19, 2024
 · 
1 min read
 · 
Lori Ellis
Pictured: WHO headquarters in Geneva, Switzerland/
GLP-1
GLP-1s Potentially ‘Transformative’ but Could Lead to ‘Distorted’ Obesity Care: WHO
December 19, 2024
 · 
2 min read
 · 
Tristan Manalac